Infinium Global Research Ventricular Assist Device Market | Page 2

Ventricular Assist Device Market: Trends and Forecast -2024
The Infinium Global Research analyzes the report of Ventricular Assist Device
Market over the period of 2018 to 2024. This report also provides detailed
qualitative and quantitative analyses of the market dynamics, market size and
future trends in Global Ventricular Assist Device Market. It will help a lot of decision
makers to develop strategies and find new opportunities in the Global markets of
Ventricular Assist Device.
The report covers market changing aspects including drivers, restraints,
opportunities, and trends expected to encouragement the expansion of the
Ventricular Assist Device Market during the said period. The report also provides
market attractiveness analysis, by geography, and market share analysis, by key
players respectively. Some of the prominent participants in the Global Ventricular
Assist Device Market are Berlin Heart GmbH, Sunshine Heart Inc., SynCardia
Systems LLC, St. Jude Medical, Heart Ware International, Abiomed, Thoratec, Jarvik
Heart, Cardiac Assist and Others. According to report the global ventricular assist
devices market is projected to grow at a CAGR of 9.5% over the forecast period of
2018-2024.
For More Details Get Free Few Sample Pages of this Premium Report: -
https://www.infiniumglobalresearch.com/reports/sample-request/132
An electromechanical device used for assisting cardiac circulation, which is used to
partially or completely replace the function of a failing heart is known as ventricular
assist device .The VADs are used for short term, for patients recovering from heart
attack and for patients recovering from cardiac surgery; the patient suffering from
advanced congestive heart failure use long-term VADs. VADs are different from
artificial hearts, which are designed to undertake cardiac function, and generally
need the removal of the patient's heart. Moreover, VADs are designed to support
either the right ventricle (RVAD) or the left ventricle (LVAD), or to assist both
ventricles (BiVAD). The left-ventricle assistance device (LVAD) is the common device
applied to a defective heart, but when the pulmonary arterial-resistance is high,
then a right-ventricle assistance device (RVAD) might be necessary to resolve the
problem of cardiac circulation. If both a LVAD and a RVAD is needed a BiVAD is
normally used.
Growth in incidence of patients with heart failure and lack of heart donors is likely
to boost the growth of the market. In addition, rising the incidence of
cardiovascular diseases such as coronary artery disease, hypertension, and heart
2
© Infinium Global Research